Intramuscular Fat and Associations With Metabolic Risk Factors in the Framingham Heart Study

Objective—Intramuscular fat accumulates between muscle fibers or within muscle cells. We investigated the association of intramuscular fat with other ectopic fat deposits and metabolic risk factors. Approach and Results—Participants (n=2945; 50.2% women; mean age 50.8 years) from the Framingham Heart Study underwent multidetector computed tomography scanning of the abdomen. Regions of interest were placed on the left and right paraspinous muscle, and the muscle attenuation (MA) in Hounsfield units was averaged. We examined the association between MA and metabolic risk factors in multivariable models, and additionally adjusted for body mass index (BMI) and visceral adipose tissue (VAT) in separate models. MA was associated with dysglycemia, dyslipidemia, and hypertension in both sexes. In women, per standard deviation decrease in MA, there was a 1.34 (95% confidence interval, 1.10–1.64) increase in the odds of diabetes mellitus, a 1.40 (95% confidence interval, 1.22–1.61) increase in the odds of high triglycerides, and a 1.29 (95% confidence interval, 1.12–1.48) increase in the odds of hypertension. However, none of these associations persisted after adjustment for BMI or VAT. In men, we observed similar patterns for most risk factors. The exception was metabolic syndrome, which retained association in women even after adjustment for BMI and VAT, and low high density lipoprotein and high triglycerides in men, whose associations also persisted after adjustment for BMI and VAT. Conclusions—MA was associated with metabolic risk factors, but most of these associations were lost after adjustment for BMI or VAT. However, a unique association remained for metabolic syndrome in women and lipids in men.

[1]  H. Bays Adiposopathy is "sick fat" a cardiovascular disease? , 2011, Journal of the American College of Cardiology.

[2]  S. Caprio,et al.  The Triglyceride-to-HDL Cholesterol Ratio Association with insulin resistance in obese youths of different ethnic background , 2011 .

[3]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[4]  Shih-Jen Hwang,et al.  Fatty Kidney, Hypertension, and Chronic Kidney Disease: The Framingham Heart Study , 2011, Hypertension.

[5]  N. Tajima,et al.  Effect of intramuscular fat difference on glucose and insulin reaction in oral glucose tolerance test. , 2006, Journal of atherosclerosis and thrombosis.

[6]  B. Rothermel,et al.  Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. , 2005, Diabetes.

[7]  K. Petersen,et al.  Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. , 2002, Diabetes.

[8]  Udo Hoffmann,et al.  Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study , 2008, Circulation.

[9]  S. Grinspoon,et al.  Psoas muscle attenuation measurement with computed tomography indicates intramuscular fat accumulation in patients with the HIV-lipodystrophy syndrome. , 2003, Journal of applied physiology.

[10]  R Ross,et al.  Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. , 2000, Journal of applied physiology.

[11]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[12]  Donald D Hensrud,et al.  Splanchnic lipolysis in human obesity. , 2004, The Journal of clinical investigation.

[13]  Simon C Watkins,et al.  Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. , 2001, The Journal of clinical endocrinology and metabolism.

[14]  Udo Hoffmann,et al.  Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study , 2007, Circulation.

[15]  M. Johnson,et al.  Data on the distribution of fibre types in thirty-six human muscles. An autopsy study. , 1973, Journal of the neurological sciences.

[16]  W. Garvey,et al.  Skeletal muscle lipid peroxidation and insulin resistance in humans. , 2012, The Journal of clinical endocrinology and metabolism.

[17]  Yiying Zhang,et al.  Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. , 2007, The Journal of clinical investigation.

[18]  D. Allison,et al.  Intramyocellular Lipid and Insulin Resistance: Differential Relationships in European and African Americans , 2011, Obesity.

[19]  W. Kannel,et al.  AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY , 1963, Annals of the New York Academy of Sciences.

[20]  Olga Ilkayeva,et al.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.

[21]  J. Sowers,et al.  The metabolic syndrome: role of skeletal muscle metabolism. , 2006, Annals of medicine.

[22]  C. Fox,et al.  Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. , 2010, Atherosclerosis.

[23]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[24]  G. Heigenhauser,et al.  Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36 , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  C. Bouchard,et al.  Mid-Thigh Subcutaneous Adipose Tissue and Glucose Tolerance in the Quebec Family Study , 2008, Obesity Facts.

[26]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[27]  C. Fox,et al.  Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography , 2007, International Journal of Obesity.

[28]  Udo Hoffmann,et al.  Abdominal Subcutaneous and Visceral Adipose Tissue and Insulin Resistance in the Framingham Heart Study , 2010, Obesity.

[29]  B. Balkau,et al.  Comment on the provisional report from the WHO consultation , 1999, Diabetic medicine : a journal of the British Diabetic Association.

[30]  Goutham Rao,et al.  Assessing adiposity: a scientific statement from the American Heart Association. , 2011, Circulation.

[31]  Udo Hoffmann,et al.  Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study , 2010, Hepatology.

[32]  Qiong Yang,et al.  The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination. , 2007, American journal of epidemiology.

[33]  R. Eckel,et al.  Increased intramuscular lipid synthesis and low saturation relate to insulin sensitivity in endurance-trained athletes. , 2010, Journal of applied physiology.

[34]  SoJung Lee,et al.  Skeletal muscle lipid content and insulin sensitivity in black versus white obese adolescents: is there a race differential? , 2010, The Journal of clinical endocrinology and metabolism.

[35]  C. Fox,et al.  Ectopic Fat Depots and Cardiovascular Disease , 2011, Circulation.

[36]  A. Uitterlinden,et al.  Sex-specific genetic effects influence variation in body composition , 2008, Diabetologia.